Macrolide-Resistant Pertussis (Whooping Cough) in Infants
The short answer
Macrolide-resistant pertussis (whooping cough) is an emerging concern, particularly in some Asian countries, though it remains uncommon in the United States. Standard treatment for pertussis is macrolide antibiotics (azithromycin, erythromycin, or clarithromycin), and resistance means these first-line drugs may be ineffective. Pertussis is most dangerous in infants under 6 months who are too young to be fully vaccinated. The Tdap vaccine during pregnancy (weeks 27-36) is the most effective way to protect newborns, as maternal antibodies transfer to the baby and provide protection until they can be vaccinated at 2 months.
This is one of the most common questions parents ask. Searching for answers means you care.
By Age
What to expect by age
0-2 months
This is the highest-risk period for severe pertussis because babies have not yet received their first DTaP vaccine dose. Pertussis in very young infants can cause apnea (breathing pauses), pneumonia, seizures, brain damage, and death. If the mother received Tdap during pregnancy, the baby has some passive protection from maternal antibodies. If a young infant develops a persistent cough, especially with a "whoop" sound, post-cough vomiting, or apnea episodes, seek immediate medical evaluation. Hospitalization for monitoring is often necessary.
2-6 months
Babies receive DTaP vaccine doses at 2, 4, and 6 months, with increasing protection after each dose. Until the series is complete, babies remain vulnerable. If pertussis is diagnosed and standard macrolide antibiotics are not effective (the baby is not improving or culture shows resistance), alternative antibiotics such as trimethoprim-sulfamethoxazole may be used, though options are limited for young infants. Close contacts of the baby should receive prophylactic antibiotics regardless of vaccination status to create a "cocoon" of protection.
6-36 months
After completing the primary DTaP series (doses at 2, 4, 6, and 15-18 months), children have good but not complete protection against pertussis. Breakthrough infections can occur but are generally milder. The emergence of macrolide resistance globally underscores the importance of vaccination, hygiene, and prompt treatment. If your child develops a persistent cough lasting more than 2 weeks with paroxysms (coughing fits), see your pediatrician for evaluation. A booster dose at 15-18 months and again at 4-6 years maintains protection.
What Should You Do?
When to take action
- Your baby has received age-appropriate DTaP vaccinations and you received Tdap during pregnancy.
- Your baby has a typical cold with cough that is improving and does not have coughing fits or vomiting after coughing.
- Your baby was treated for pertussis with antibiotics and is recovering as expected.
- Your baby has a cough that has lasted more than 2 weeks and includes paroxysms (fits of rapid coughing).
- Your baby vomits after coughing episodes or makes a "whooping" sound when breathing in after coughing.
- You or a close contact of your baby has been diagnosed with pertussis.
- Your baby was treated for pertussis but is not improving on antibiotics.
- Your baby under 6 months has episodes of apnea (stops breathing), turns blue, or has extreme difficulty breathing.
- Your baby has uncontrollable coughing fits that prevent breathing or feeding.
- Your newborn has any signs of respiratory distress: grunting, nasal flaring, chest retractions, or persistent cough.
Sources
Related Resources
Trust your instincts. If something feels wrong, reach out to your pediatrician.
Worrying about your baby means you care. That is a good thing.
Related Medical Concerns
RSV in Babies: What to Know
RSV (respiratory syncytial virus) is a common virus that affects nearly all children by age 2. Most babies have mild cold-like symptoms, but some, especially young infants and those with underlying conditions, can develop breathing difficulties. Watch for fast breathing, flaring nostrils, or visible chest pulling - these are signs to seek medical care.
My Baby Is Breathing Fast
Babies normally breathe faster than adults. A normal respiratory rate for a newborn is 30-60 breaths per minute, slowing to 20-40 by age 1. Brief episodes of faster breathing during excitement, crying, or feeding are normal. However, persistently rapid breathing (tachypnea) at rest, especially with other signs of respiratory distress, may indicate a lung or heart problem that needs prompt evaluation.
Baby Wheezing
Wheezing is a high-pitched whistling sound heard during breathing out, caused by narrowed airways. In babies, the most common cause is a viral infection like bronchiolitis (often RSV). Many babies wheeze once or twice during their first viral illnesses and never wheeze again. However, wheezing with breathing difficulty always warrants medical evaluation.
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.